R. Melki

发表

Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization

H. Fahmi, M. Fayyad-kazan, M. Najar, 2022, Frontiers in Cell and Developmental Biology.

New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways

N. Boukhatem, A. Hamal, M. Najimi, 2021, Molecules.

Genetic Heterogeneity in Moroccan Primary Congenital Glaucoma Patients

A. Belmouden, R. Melki, Soumaya El Akil, 2014 .

The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells

T. Vanhaecke, V. Rogiers, H. Fahmi, 2020, Journal of clinical medicine.

Transcriptional Profile of Cytokines, Regulatory Mediators and TLR in Mesenchymal Stromal Cells after Inflammatory Signaling and Cell-Passaging

T. Vanhaecke, V. Rogiers, H. Fahmi, 2021, International journal of molecular sciences.

The biological response of mesenchymal stromal cells to thymol and carvacrol in comparison to their essential oil: An innovative new study.

A. Hamal, M. Najimi, M. Najar, 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges

H. Afif, H. Fahmi, A. Hamal, 2019, Journal of clinical medicine.

Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases

J. Twizere, M. Najimi, M. Najar, 2022, Inflammation Research.

Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes.

H. Garchon, D. Damotte, A. Herbelin, 2006, Diabetes.

Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes.

H. Garchon, D. Damotte, A. Herbelin, 2006, Diabetes.

CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma

H. Garchon, A. Brézin, R. Melki, 2004, Journal of Medical Genetics.

CYP 1 B 1 mutations in French patients with early-onset primary open-angle glaucoma

H. Garchon, A. Brézin, R. Melki, 2004 .

A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco

H. Garchon, S. Nadifi, A. Belmouden, 2002, Clinical genetics.

Empowering the immune fate of bone marrow mesenchymal stromal cells: gene and protein changes

H. Afif, H. Fahmi, N. Boukhatem, 2018, Inflammation Research.

Association of a common coding polymorphism (N453S) of the cytochrome P450 1B1 (CYP1B1) gene with optic disc cupping and visual field alteration in French patients with primary open-angle glaucoma.

H. Garchon, A. Brézin, R. Melki, 2005, Molecular vision.

Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling

N. Boukhatem, T. El Harroudi, R. Melki, 2023, BMC Cancer.

The M98K variant of the OPTINEURIN (OPTN) gene modifies initial intraocular pressure in patients with primary open angle glaucoma

H. Garchon, A. Brézin, A. Belmouden, 2003, Journal of medical genetics.

Mutational analysis of the MYOCILIN gene in patients with primary open-angle glaucoma in Morocco

A. Belmouden, R. Melki, O. Akhayat, 2003, Ophthalmic genetics.

Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study

N. Boukhatem, T. El Harroudi, R. Melki, 2018, BMC Cancer.

Myocilin analysis by DHPLC in French POAG patients: Increased prevalence of Q368X mutation

H. Garchon, A. Brézin, A. Belmouden, 2003, Human mutation.